Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.31
Price to sales ratio
53.24

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3412
AVNW
Aviat Networks, Inc. - Common Stock
21.08 USD-2.63%-0.14%+0.38%-16.75%272.76 M USD
3496
SILC
Silicom Ltd - Ordinary Shares
42.67 USD-3.40%+0.71%-10.75%+146.79%243.48 M USD
3596
LTRX
Lantronix, Inc. - Common Stock
5.31 USD-5.18%-4.67%-23.38%+77.00%211.43 M USD
3622
CRNT
Ceragon Networks Ltd. - Ordinary Shares
2.29 USD-2.55%-4.98%-25.41%-6.15%202.42 M USD

Frequently asked questions about CAMP4 Therapeutics Corporation - Common Stock

What is the CAMP4 Therapeutics Corporation - Common Stock stock price today?

The current price of CAMP4 Therapeutics Corporation - Common Stock (CAMP) is 4.5. Over the past 24 hours, the stock has changed by +3.93%. Follow the CAMP chart for real-time price dynamics.

What is the stock ticker of CAMP4 Therapeutics Corporation - Common Stock?

CAMP4 Therapeutics Corporation - Common Stock trades under the ticker CAMP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is CAMP4 Therapeutics Corporation - Common Stock stock going up?

CAMP has changed by +5.63% over the last week, +7.40% over the last month, and +12.22% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was CAMP4 Therapeutics Corporation - Common Stock net income for the last quarter?

CAMP4 Therapeutics Corporation - Common Stock reported net income of -18.33 M for the last quarter. The previous quarter showed -40.28 M, which means net income changed by +54.50%.

How many employees does CAMP4 Therapeutics Corporation - Common Stock have?

As of the latest available data, CAMP4 Therapeutics Corporation - Common Stock has 48 employees. Workforce size can provide additional context about the company's scale and operations.

What is CAMP4 Therapeutics Corporation - Common Stock EBITDA?

CAMP4 Therapeutics Corporation - Common Stock EBITDA is -12.55 M, and its EBITDA margin is -969.94%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy CAMP4 Therapeutics Corporation - Common Stock stock?

You can buy CAMP4 Therapeutics Corporation - Common Stock (CAMP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in CAMP4 Therapeutics Corporation - Common Stock stock?

Investing in CAMP4 Therapeutics Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CAMP chart and related analysis on metatrader.com as part of your research.

News